CVE-2026-14522

CVE-2026-14522 is a high-severity vulnerability in Ibm App Connect Enterprise with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

IBM App Connect Enterprise 13.0.1.0 through 13.0.7.2, and 12.0.1.0 through 12.0.12.27 could allow a remote attacker to execute arbitrary commands due to improper neutralization of CRLF characters.

Frequently asked questions

What is CVE-2026-14522?
IBM App Connect Enterprise 13.0.1.0 through 13.0.7.2, and 12.0.1.0 through 12.0.12.27 could allow a remote attacker to execute arbitrary commands due to improper neutralization of CRLF characters.
How severe is CVE-2026-14522?
CVE-2026-14522 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2026-14522 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (61st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-14522?
CVE-2026-14522 affects Ibm App Connect Enterprise. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-14522?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2026-14522 published?
CVE-2026-14522 was published on 2026-07-30 and last updated on 2026-08-05.

References

Affected products (1)

More vulnerabilities in Ibm App Connect Enterprise

All CVEs affecting Ibm App Connect Enterprise →

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →